InvestorsHub Logo
Followers 55
Posts 1664
Boards Moderated 0
Alias Born 12/11/2012

Re: $heff post# 82722

Tuesday, 09/16/2014 10:12:48 AM

Tuesday, September 16, 2014 10:12:48 AM

Post# of 97239
CNAT $6.65-Added long position. Multiple catalysts ahead. This should get attention soon. It's a Liver disease play !

Lots of Upcoming key catalysts:
(1)ACLF-Phase 2b trial results sufficient to inform on Phase 3
opportunity expected by end of 2014
(2) POLT -HCV - SVR Phase 2b - Initial interim results expected in 1H15
(3)NAFLD/NASH Phase 2 -- Phase 2 trial results expected 1Q15
(4)Liver cirrhosis - Phase 2 interim trial expected 2H15
(5) Portal Hypertension - Phase 2 trial results expected 3Q15


More info can be found in the presentation :
http://files.shareholder.com/downloads/AMDA-20JRI1/3474597647x0x779074/23bdaeb6-f711-42d4-9bda-df0fa372a401/140902%20CNAT%20Update.pdf

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.